Skip to content

Clinical observations of Ayurvedic Sirolepa Therapy in Chronic Spontaneous Urticaria

Clinical observations of Ayurvedic Sirolepa Therapy as an add-on to Standard of Care in Patients with Chronic Spontaneous Urticaria: A Case Series - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/098049
Enrollment
8
Registered
2025-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Central Council for Research in Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of CSU (Urticaria of more than 06 weeks duration despite the use of H1 antihistamine and without any known triggers) 2. Patients of any gender, with age between 18-60 years 3. Hives and itching for more than 06 weeks despite using H1 antihistamines 4. UAS7 Score more than or equal to 16 5. Willing to participate in the case series by signing the Informed Consent Form

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
UAS7 is selected as the Primary Outcome measureTimepoint: Baseline, 30th Day, 60th Day

Secondary

MeasureTime frame
Change in the Urticaria Control Test Scores in both groups at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day;Change in Quality of sleep assessed by using PSQI scale at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day;Change in quality of life by Perceived Stress Scale (PSS) Score at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day;Proportion of patients who experienced Adverse Drug Reactions(s) at the end of 60th day 3 daysTimepoint: 30th Day, 60th Day;Percentage of participants requiring dose escalation at the end of 60th day 3 daysTimepoint: 30th Day, 60th Day;Change in Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day

Countries

India

Contacts

Public ContactMIDHUNA MOHAN K

Regional Ayurveda Research Institute, Vijayawada

midhunamohan@gmail.com9447894680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026